Maximus, Inc. (MMS) To Go Ex-Dividend on May 15th

Maximus, Inc. (NYSE:MMSGet Free Report) declared a quarterly dividend on Monday, April 7th, RTT News reports. Stockholders of record on Thursday, May 15th will be paid a dividend of 0.30 per share by the health services provider on Saturday, May 31st. This represents a $1.20 annualized dividend and a dividend yield of 1.56%. The ex-dividend date of this dividend is Thursday, May 15th.

Maximus has increased its dividend payment by an average of 2.3% per year over the last three years and has increased its dividend every year for the last 2 years. Maximus has a payout ratio of 18.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 20.8%.

Maximus Trading Up 2.1%

MMS opened at $76.88 on Tuesday. The stock has a market capitalization of $4.35 billion, a P/E ratio of 16.53 and a beta of 0.61. Maximus has a 12 month low of $63.77 and a 12 month high of $93.97. The firm’s fifty day simple moving average is $68.25 and its 200 day simple moving average is $72.89. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMSGet Free Report) last issued its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same period in the previous year, the firm posted $1.57 EPS. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. As a group, research analysts anticipate that Maximus will post 6.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a report on Wednesday, May 7th.

View Our Latest Report on MMS

Insider Activity

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88% decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Further Reading

Dividend History for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.